Analytical Data
-
基因名
FBA1
- Application
-
别名
37 kDa major allergen (Fructose-1,6-bisphosphate aldolase) (IgE-binding allergen) (FBP aldolase) (FBPA)
-
种属
Candida albicans
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9URB4
-
表达区间
2-359aa
-
分子量
46.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FBA1, or fructose-bisphosphate aldolase 1, is an enzyme that plays a crucial role in the glycolytic pathway, catalyzing the reversible conversion of fructose-1,6-bisphosphate into dihydroxyacetone phosphate and glyceraldehyde-3-phosphate. Research on FBA1 has garnered interest due to its significance in cellular metabolism, energy production, and its potential implications in various diseases, including cancer and metabolic disorders. The study of FBA1 recombinant protein allows for a better understanding of its structural and functional properties, enabling researchers to investigate its enzymatic mechanism, regulation, and interactions with other metabolic pathways. Furthermore, characterizing FBA1 as a recombinant protein facilitates its use in biochemical assays and drug development, providing insights into the design of inhibitors or modulators that could have therapeutic applications. By elucidating the role of FBA1 in cellular processes and its involvement in pathophysiological conditions, scientists aim to uncover new targets for therapeutic intervention and develop strategies to modulate its activity for clinical benefits. Overall, the investigation of FBA1 recombinant protein lies at the intersection of biochemistry, molecular biology, and pharmacology, holding promise for advancing our understanding of metabolic diseases and developing targeted treatment strategies.
